JHepatol[Jour]AND74[volume]AND6[issue]
肝病学杂志74卷6期
1
Associationofliverabnormalitieswithin-hospitalmortalityinpatientswithCOVID-19.
COVID-19患者肝脏异常与住院死亡率的关系。
DingZY,LiGX,ChenL,ShuC,SongJ,WangW,WangYW,ChenQ,JinGN,LiuTT,LiangJN,ZhuP,ZhuW,LiY,ZhangBH,FengH,ZhangWG,YinZY,YuWK,YangY,ZhangHQ,TangZP,WangH,HuJB,LiuJH,YinP,ChenXP,ZhangB;TongjiMultidisciplinaryTeamforTreatingCOVID-19(TTTC).
JHepatol.Jun;74(6):-.
2
SynthetichumanABCB4mRNAtherapyrescuessevereliverdiseasephenotypeinaBALB/c.Abcb4-/-mousemodelofPFIC3.
合成人ABCB4mRNA治疗拯救BALB/c中的严重肝病表型。ABCB4-/-PFIC3小鼠模型。
WeiG,CaoJ,HuangP,AnP,BadlaniD,VaidKA,ZhaoS,WangDQ,ZhuoJ,YinL,FrassettoA,MarkelA,PresnyakV,GandhamS,HuaS,LukacsC,FinnPF,GiangrandePH,MartiniPGV,PopovYV.
JHepatol.Jun;74(6):-.
3
Mitochondrialoxidativemetabolismcontributestoacancerstemcellphenotypeincholangiocarcinoma.
线粒体氧化代谢对胆管癌干细胞表型的影响。
RaggiC,TaddeiML,SaccoE,NavariN,CorrentiM,PiombantiB,PastoreM,CampaniC,PranziniE,IorioJ,LoriG,LottiniT,PeanoC,CibellaJ,LewinskaM,AndersenJB,diTommasoL,ViganòL,DiMairaG,MadiaiS,RamazzottiM,OrlandiI,ArcangeliA,ChiarugiP,MarraF.
JHepatol.Jun;74(6):-.
4
Cost-effectivenessofalcoholusetreatmentsinpatientswithalcohol-relatedcirrhosis.
酒精性肝硬化患者酒精使用治疗的成本效益。
Avance?aALV,MillerN,UttalSE,HuttonDW,MellingerJL.
JHepatol.Jun;74(6):-.
5
RoleofcoreproteinmutationsinthedevelopmentofoccultHBVinfection.
核心蛋白突变在隐匿性HBV感染发展中的作用。
ChenJ,LiuB,TangX,ZhengX,LuJ,ZhangL,WangW,CandottiD,FuY,AllainJP,LiC,LiL,LiT.
JHepatol.Jun;74(6):-.
6
ExpressionofNKG2Dligandsisdownregulatedbyβ-cateninsignallingandassociateswithHCCaggressiveness.
NKG2D配体的表达受到β-连环蛋白信号转导与肝癌侵袭性相关。
CadouxM,CarusoS,PhamS,GougeletA,PophillatC,RiouR,LoeschR,ColnotS,NguyenCT,CalderaroJ,Celton-MorizurS,GuerraN,Zucman-RossiJ,DesdouetsC,CoutyJP.
JHepatol.Jun;74(6):-.
7
ValidatinganovelscorebasedoninteractionbetweenACLFgradeandMELDscoretopredictwaitlistmortality.
基于ACLF评分和MELD评分之间的交互作用验证一个新的评分来预测等待名单死亡率。
AbdallahMA,KuoYF,AsraniS,WongRJ,AhmedA,KwoP,TerraultN,KamathPS,JalanR,SingalAK.
JHepatol.Jun;74(6):-.
8
PredictingsurvivalafterlivertransplantationinpatientswithhepatocellularcarcinomausingtheLiTES-HCCscore.
应用LiTES-HCC评分预测肝细胞癌患者肝移植术后生存率。
GoldbergD,ManteroA,New